ArticleBritish journal of cancer2025

AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma.

Lindsay C Spender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.